AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy. (2021)
Attributed to:
Exosomal protein deficiencies: how abnormal RNA metabolism results in childhood-onset neurological diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41434-021-00250-0
PubMed Identifier: 33692503
Publication URI: http://europepmc.org/abstract/MED/33692503
Type: Journal Article/Review
Volume: 28
Parent Publication: Gene therapy
Issue: 10-11
ISSN: 0969-7128